OXFORD UK – September 9, 2013
Orca Pharmaceuticals, a new biotechnology start-up focused on treating autoimmune diseases, announces its formation with funding from BioMotiv, a Cleveland, Ohio based therapeutics accelerator affiliated with The Harrington Project, and the New York University Innovation Venture Fund. The company, located in Oxford UK, is based on technology developed by inventors from New York University (NYU) in collaboration with the founders in the United Kingdom.

Click to view full release